Summary
University of South Florida (USF) is an educational university that conducts research services. The university offers undergraduate, graduate, and research programs in fields of business, science, law, social sciences, and medicine. It provides courses in various fields including accounting, advertising, Africana studies, American studies, anthropology, applied science, behavioral healthcare, adult community services, and others. USF offers courses on behavioral healthcare, biomedical sciences, cell and molecular biology, communication, communication sciences and disorders, entrepreneurship in applied technologies and environmental engineering, among others. The university also provides distance and online learning, workforce development, noncredit education, pre-college programs and other. It has campuses in Tampa, St. Petersburg, Sarasota-Manatee and Lakeland. USF is headquartered in Tampa, Florida, the US.
University of South Florida - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
University of South Florida, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of South Florida, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of South Florida, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of South Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of South Florida, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
University of South Florida, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Jackson Lab Partners With University of South Florida 10
Licensing Agreements 11
Agilis Biotherapeutics Enters into Licensing Agreement with University of South Florida 11
Agilis Biotherapeutics Enters into Licensing Agreement with University of South Florida 12
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 13
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 15
Asset Transactions 16
Cellular Biomedicine Acquires Rights to CD40LGVAX Vaccine for USD4.3 Million 16
University of South Florida - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21
List of Tables
University of South Florida, Pharmaceuticals & Healthcare, Key Facts 1
University of South Florida, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of South Florida, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of South Florida, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of South Florida, Deals By Therapy Area, 2010 to YTD 2016 8
University of South Florida, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Jackson Lab Partners With University of South Florida 10
Agilis Biotherapeutics Enters into Licensing Agreement with University of South Florida 11
Agilis Biotherapeutics Enters into Licensing Agreement with University of South Florida 12
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 13
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 15
Cellular Biomedicine Acquires Rights to CD40LGVAX Vaccine for USD4.3 Million 16
University of South Florida, Key Competitors 18
University of South Florida, Key Employees 19
University of South Florida, Subsidiaries 20
List of Figures
University of South Florida, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of South Florida, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of South Florida, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of South Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of South Florida, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of South Florida, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
University of South Florida, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of South Florida, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8